Open AccessHigh-flow nasal cannula for Acute Respiratory Distress Syndrome (ARDS) due to COVID-19
Author(s) -
Carolina Panadero,
Araceli Abad Fernández,
María Teresa Río Ramírez,
Carmen Maria Acosta Gutiérrez,
Mariara Calderón-Alcalá,
Cristina López-Riolobos,
Cristina Matesanz-López,
Fernando García-Prieto,
José María Díaz-García,
Beatriz Raboso Moreno,
Zully Vasquez-Gambasica,
Pilar Andres-Ruzafa,
Jose Luis García-Satué,
Sara Calero-Pardo,
Belén Sagastizábal,
Diego Bautista,
Alfonso Campos,
Marina González,
Luís Grande,
Marta Jiménez Fernández,
Jose L. Santiago-Ruiz,
Pedro Caravaca Pérez,
Andrés J. Alcaraz Romero
Publication year - 2020
Publication title -
multidisciplinary respiratory medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.72
H-Index - 28
eISSN - 2049-6958
pISSN - 1828-695X
DOI - 10.4081/mrm.2020.693
Subject(s) - nasal cannula , ards , medicine , intubation , oxygen therapy , anesthesia , pneumonia , respiratory distress , retrospective cohort study , cannula , surgery , lung
High-flow therapy is a useful treatment in ARDS in order to avoid intubation or as a bridge therapy, and no increased mortality was observed secondary to the delay in intubation. After initiating HFNC, a ROX index below 4.94 predicts the need for intubation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom